Prestige Consumer Healthcare Inc.
PBH · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $274 | $250 | $297 | $290 |
| % Growth | 9.9% | -15.9% | 2.2% | – |
| Cost of Goods Sold | $120 | $114 | $121 | $129 |
| Gross Profit | $154 | $135 | $176 | $161 |
| % Margin | 56.2% | 54.2% | 59.2% | 55.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $28 | $28 | $27 | $26 |
| SG&A Expenses | $67 | $63 | $64 | $64 |
| Sales & Mktg Exp. | $39 | $35 | $37 | $38 |
| Other Operating Expenses | $8 | $0 | $23 | $5 |
| Operating Expenses | $74 | $63 | $87 | $69 |
| Operating Income | $80 | $72 | $88 | $92 |
| % Margin | 29.1% | 28.8% | 29.8% | 31.7% |
| Other Income/Exp. Net | -$11 | -$10 | -$14 | -$12 |
| Pre-Tax Income | $69 | $62 | $74 | $80 |
| Tax Expense | $27 | $14 | $24 | $19 |
| Net Income | $42 | $47 | $50 | $61 |
| % Margin | 15.4% | 19% | 16.9% | 21% |
| EPS | 0.86 | 0.96 | 1.01 | 1.23 |
| % Growth | -10.4% | -5% | -17.9% | – |
| EPS Diluted | 0.86 | 0.95 | 1 | 1.22 |
| Weighted Avg Shares Out | 49 | 49 | 50 | 50 |
| Weighted Avg Shares Out Dil | 49 | 50 | 50 | 50 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $10 | $10 | $11 | $11 |
| Depreciation & Amortization | $8 | $8 | $7 | $7 |
| EBITDA | $87 | $80 | $92 | $98 |
| % Margin | 31.7% | 31.9% | 31% | 33.9% |